Duration of antiretroviral therapy adherence interruption is associated with risk of virologic rebound as determined by real-time adherence monitoring in rural Uganda

Jessica E. Haberer, Nicholas Musinguzi, Yap Boum, Mark J. Siedner, A. Rain Mocello, Peter W. Hunt, Jeffrey N. Martin, David R. Bangsberg

Research output: Contribution to journalArticlepeer-review

49 Scopus citations

Fingerprint

Dive into the research topics of 'Duration of antiretroviral therapy adherence interruption is associated with risk of virologic rebound as determined by real-time adherence monitoring in rural Uganda'. Together they form a unique fingerprint.

Medicine & Life Sciences